Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Onconetix (ONCO) EBIT Margin (2023 - 2025)

Historic EBIT Margin for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to 681.45%.

  • Onconetix's EBIT Margin fell 311400.0% to 681.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 3736.17%, marking a year-over-year decrease of 6940800.0%. This contributed to the annual value of 2237.96% for FY2024, which is 593965100.0% up from last year.
  • As of Q3 2025, Onconetix's EBIT Margin stood at 681.45%, which was down 311400.0% from 1817.4% recorded in Q2 2025.
  • Over the past 5 years, Onconetix's EBIT Margin peaked at 11694.91% during Q4 2023, and registered a low of 12369.21% during Q1 2025.
  • In the last 3 years, Onconetix's EBIT Margin had a median value of 1131.81% in 2024 and averaged 665.57%.
  • Per our database at Business Quant, Onconetix's EBIT Margin plummeted by -157885700bps in 2024 and then skyrocketed by 1142300bps in 2025.
  • Quarter analysis of 3 years shows Onconetix's EBIT Margin stood at 11694.91% in 2023, then tumbled by -135bps to 4093.66% in 2024, then surged by 83bps to 681.45% in 2025.
  • Its EBIT Margin stands at 681.45% for Q3 2025, versus 1817.4% for Q2 2025 and 12369.21% for Q1 2025.